What is hyaluronic acid and where does it live in the mouth?

Hyaluronic acid is a glycosaminoglycan: a long-chain polysaccharide built from repeating disaccharide units of glucuronic acid and N-acetylglucosamine. Your body synthesises it continuously using an enzyme family called hyaluronan synthases, and it is found in almost every tissue that requires hydration, lubrication, or structural integrity, including articular cartilage, the vitreous humour of the eye, and the dermis of the skin.

In the mouth, HA is present in the gingival connective tissue (the dense fibrous layer sitting beneath the gum surface epithelium), in the periodontal ligament that anchors each tooth root to its surrounding alveolar bone, and in smaller concentrations in saliva itself. Its primary function in these locations is to maintain tissue architecture. HA molecules can hold up to 1,000 times their own weight in water, creating a hydrated extracellular matrix that cushions mechanical forces during chewing and provides a scaffold for fibroblast and keratinocyte activity.

Healthy gingival tissue has a relatively high and uniformly distributed HA content. Histological studies using alcian blue and Hyaluronan Binding Protein staining confirm that HA in healthy tissue is concentrated around blood vessels and connective tissue fibres. This distribution positions HA as a key regulator of tissue permeability, cell migration, and local immune surveillance, all of which become critically important when bacteria at the gum margin trigger an inflammatory response.

The molecular weight of HA varies widely across biological contexts and commercial products. Native tissue HA averages between 6,000 and 12,000 kDa. During inflammation, enzymatic and radical-mediated fragmentation cleaves these long chains into shorter oligosaccharides with fundamentally different biological activities. This distinction between high-molecular-weight and low-molecular-weight HA is central to understanding how topical HA products might produce measurable clinical effects and why not all HA products behave the same way.

How gum inflammation depletes native hyaluronic acid

When dental plaque accumulates at the gingival margin, resident bacteria release lipopolysaccharides, proteases, and other virulence factors that activate the host immune system. Neutrophils migrate to the site within hours, followed by macrophages and lymphocytes over the following days. These immune cells release a cascade of reactive oxygen species and matrix metalloproteinases that begin degrading the extracellular matrix.

Among the enzymes released during this inflammatory process is bacterial hyaluronidase, particularly from Streptococcus mutans and several periodontal pathogens including Porphyromonas gingivalis. This enzyme cleaves native high-molecular-weight HA chains into progressively smaller oligosaccharide fragments. The consequences extend far beyond simple structural degradation. Low-molecular-weight HA fragments (below approximately 500 kDa) act as damage-associated molecular patterns, binding to pattern recognition receptors including CD44, RHAMM, and toll-like receptors 2 and 4. This binding amplifies the inflammatory cascade, driving further interleukin-1 beta, interleukin-6, and tumour necrosis factor-alpha production, which in turn perpetuates matrix breakdown.

Research published in the Journal of Periodontology has confirmed that gingival biopsies from patients with chronic periodontitis show significantly lower HA staining intensity and a more fragmented HA distribution pattern compared to tissue from periodontally healthy controls. This depletion is not a side effect of disease; it actively worsens it. The structural weakening of the extracellular matrix makes the tissue more permeable to bacterial invasion, and the pro-inflammatory HA fragments extend and amplify local immune activation.

This cycle partly explains why gum disease is so difficult to resolve without professional intervention, even with improved home care. The degraded matrix environment makes it harder for tissue repair processes to re-establish themselves once plaque accumulation has triggered meaningful inflammation. Replenishing HA in the local tissue environment after professional debridement is therefore a mechanistically coherent therapeutic approach, even if the clinical evidence for its scale of benefit is still developing.

Topical HA and bleeding gums: the clinical trial record

Bleeding on probing is one of the primary clinical measures of gingival inflammation. A blunt calibrated probe is inserted to the base of the sulcus around each tooth; if the tissue bleeds within 30 seconds, the sulcular epithelium is sufficiently thin and inflamed to rupture under minimal mechanical force. Reducing this bleeding index is a core treatment goal because persistent sulcular inflammation correlates with progressive bone and attachment loss over the years.

A 2022 randomised controlled trial published in Clinical Oral Investigations enrolled 60 patients with mild to moderate chronic periodontitis. Participants received either scaling and root planing alone or scaling combined with adjunctive 0.2% HA gel instilled directly into periodontal pockets at baseline, 4 weeks, and 8 weeks. At 12-week follow-up, the HA group showed a 38% reduction in bleeding on probing versus 22% in the scaling-only group, with the gingival index score also improving significantly in the HA arm. The differences were modest in absolute terms but consistent across patients and statistically robust after adjustment for baseline severity.

A systematic review published in the Journal of Periodontology in 2019 pooled data from seven randomised controlled trials involving 382 patients with gingivitis or chronic periodontitis. The meta-analysis found that topical HA used as an adjunct to mechanical debridement produced small but statistically significant reductions in both bleeding on probing and probing pocket depth at 3- to 6-month follow-up. The authors noted substantial heterogeneity between trials regarding HA concentration (ranging from 0.2% to 0.8%), molecular weight, application vehicle (gels vs rinses), application frequency, and follow-up duration, which limits the ability to draw conclusions about optimal treatment protocols from the pooled data alone.

Studies using HA mouthrinses rather than professionally applied in-pocket gels have generally returned weaker results. A 2020 double-blind trial published in BDJ Open found that twice-daily rinsing with a 0.4% HA solution for 8 weeks produced a modest reduction in gingival index compared to placebo rinse, but the difference narrowed considerably after statistical adjustment for baseline plaque scores. The researchers concluded that rinse formats may benefit mild gingivitis but are unlikely to match the effects of professionally delivered in-pocket gels in established periodontitis, where higher local concentrations and longer tissue contact time are probably required.

Pocket depth reduction: what the numbers show

Probing pocket depth (PPD) is measured in millimetres from the free gingival margin to the base of the periodontal pocket. Values of 1 to 3 mm represent healthy sulci. Depths of 4 to 6 mm indicate moderate periodontitis; values above 6 mm suggest severe disease with significant bone and attachment loss. Reducing PPD after treatment is a primary clinical goal because deeper pockets harbour more anaerobic bacteria and are inaccessible to home hygiene tools.

The pooled analysis from the 2019 Journal of Periodontology systematic review found an average PPD reduction of 0.31 mm favouring HA-adjunct treatment over scaling alone across all included trials. In periodontology, a quarter to half a millimetre difference in pocket depth at 3- to 6-month follow-up represents a meaningful clinical outcome, particularly for patients with moderate disease where every millimetre of improvement reduces the maintenance burden and the risk of disease reactivation.

The mechanism is not that HA physically fills pockets. Rather, the evidence points to fibroblast stimulation: HA binds to CD44 and RHAMM receptors on fibroblasts, promoting collagen type I and III synthesis and reorganisation of gingival connective tissue fibres. Over weeks to months, this supports coronal migration of the junctional epithelium, the biological process that reduces probing depth by re-establishing a tighter epithelial attachment closer to the cemento-enamel junction.

A 2021 study in the Journal of Dentistry compared three adjunctive delivery systems applied after scaling: HA gel alone, chlorhexidine gel alone, and a HA-chlorhexidine combination. All three groups showed PPD reductions beyond scaling alone at 6 months. The combination group performed slightly better on bleeding outcomes, while HA alone matched chlorhexidine for pocket depth improvement without the side effects of tooth staining and altered taste perception that frequently accompany chlorhexidine use. The researchers concluded that HA represents a clinically viable alternative adjunct for patients who are intolerant of or unwilling to use chlorhexidine products.

Wound healing after dental surgery: where the evidence is strongest

The most consistent body of evidence for hyaluronic acid in oral medicine concerns post-surgical wound healing rather than ongoing periodontal maintenance. After tooth extraction, gum surgery, or implant placement, the oral environment presents significant challenges: a constantly moist field, a high bacterial load, and continuous mechanical disruption from swallowing and eating. HA-based wound dressings and in-socket gels have been tested as a way to improve healing outcomes in this context, and the results are generally more convincing than those from maintenance studies.

A randomised trial published in the Journal of Oral and Maxillofacial Surgery found that applying a 0.8% HA gel to extraction sockets immediately after molar removal significantly reduced pain scores at 24 and 48 hours and produced faster soft tissue closure compared to the control group receiving no local intervention. The researchers attributed these findings to HA forming a viscous protective barrier over the wound surface, reducing bacterial contamination and desiccation of the blood clot while simultaneously providing a scaffold that granulation tissue can form over and through.

In guided bone regeneration procedures, HA has been combined with bone graft materials to improve handling properties and maintain space under collagen membranes. A 2020 study in Clinical Oral Investigations assessed HA-enhanced collagen membranes in 24 patients undergoing ridge preservation. Histological analysis of core biopsies at 6 months showed no statistically significant difference in newly formed bone volume between the HA-enhanced and standard membranes, but the HA group showed a consistent trend toward better soft tissue wound closure at the 2-week mark, suggesting the primary benefit operates in the early inflammatory and proliferative healing phases rather than in the later bone remodelling phase.

For recurrent aphthous ulcers and oral mucositis, topical HA gels have demonstrated an ability to accelerate re-epithelialisation. Studies confirm that HA promotes keratinocyte migration across the wound bed, a critical early step in restoring the protective epithelial barrier. In a Cochrane-reviewed summary of interventions for recurrent aphthous ulceration, HA gels reduced healing time and pain scores compared to placebo in multiple trials, though the overall quality of evidence was rated as moderate due to small sample sizes and variability in ulcer grading systems.

The reason wound healing evidence is stronger than maintenance evidence likely comes down to delivery and concentration. In a fresh surgical wound, HA gel is applied at high concentration directly to exposed connective tissue and remains in contact substantially longer before salivary dilution occurs. In the sulcus of an intact tooth with active gingival fluid flow, even professionally applied gels are progressively diluted and mechanically expelled, reducing the effective tissue concentration over time.

Molecular weight: why it changes everything about HA products

Molecular weight (MW) is arguably the most important and most frequently ignored parameter when evaluating hyaluronic acid oral care products. The MW determines how HA behaves at the tissue surface, how it interacts with cell surface receptors, and whether its net effect is anti-inflammatory or, counterintuitively, pro-inflammatory.

High-molecular-weight HA (above 500 kDa)

High-MW HA forms a viscous, gel-like coating on mucosal surfaces. It creates a physical moisture barrier that limits desiccation, reduces bacterial adhesion to epithelial cells, and protects the underlying tissue from mechanical abrasion during eating and speaking. At the signalling level, high-MW HA binding to CD44 receptors drives anti-inflammatory gene expression, suppressing nuclear factor kappa-B activation and reducing the production of tumour necrosis factor-alpha and interleukin-6. It also stimulates fibroblasts to synthesise more endogenous HA, creating a positive feedback loop that can help restore a depleted extracellular matrix environment.

Low-molecular-weight HA (50 to 300 kDa)

Low-MW HA has smaller chains that penetrate the epithelial barrier more readily than their high-MW counterparts. At moderate concentrations, low-MW HA can stimulate angiogenesis (new blood vessel formation) and keratinocyte migration, both useful activities during wound repair. However, very small HA fragments (below 10 kDa), the oligosaccharides generated during active periodontitis by bacterial and reactive-oxygen-species-mediated degradation, bind to toll-like receptors 2 and 4 and activate the same inflammatory pathways as microbial lipopolysaccharides. This is why the chronically inflamed periodontitis environment becomes self-perpetuating: the disease-generated HA fragments actively sustain the inflammatory state.

Several commercial dental HA products now specify their molecular weight range on packaging, and a growing number use combinations of fractions: typically a high-MW base for barrier and anti-inflammatory effects and a controlled low-to-medium-MW component for tissue penetration and angiogenic stimulation. If a product lists only "hyaluronic acid" with no MW specification, it is difficult to predict its net behaviour at the tissue level. This opacity makes it challenging for consumers and clinicians to compare products meaningfully.

HA in daily oral hygiene products: formats and limitations

Following the periodontal research literature, consumer brands began incorporating hyaluronic acid into toothpastes, mouthwashes, and gum serums. The formulation challenges are significant. Resting salivary flow rates average 0.3 to 0.4 mL per minute and increase substantially during eating and speaking. Oral pH fluctuates from below 5.5 during sugar challenges to above 7 between meals. Temperature is constant at approximately 37 degrees Celsius. Together these conditions degrade HA faster than in a sealed product tube, requiring careful pH buffering and often microencapsulation to deliver meaningful HA concentrations to tissue.

Toothpastes containing HA face an additional challenge: the brushing action that mechanically disrupts plaque also disrupts the HA film before it has had meaningful contact time with the gingival tissue. Most of the HA in a toothpaste is rinsed away within 30 seconds of application. The most effective home-care format appears to be a concentrated gel or serum applied directly to the gum margin after brushing and flossing, allowed to remain in contact for several minutes before dilution by saliva reduces its concentration.

Mouthwashes occupy an intermediate position. A 30-second rinse is unlikely to achieve significant tissue penetration, but the rinsing motion distributes HA across all mucosal surfaces including the interproximal areas between teeth that spot-applied gels commonly miss. For patients with generalised gingivitis involving multiple sextants rather than isolated pockets, the whole-mouth coverage of a rinse may offer practical advantages over the precision application required by gels.

Bioadhesive HA formats represent an emerging area. Polymer systems using hydroxypropyl methylcellulose, carbomer, or chitosan as mucoadhesive carriers extend HA residence time on the gingival surface from seconds to tens of minutes. Early clinical data on these patch and film formats is promising. If they can reliably deliver therapeutic HA concentrations to sulcular tissue for sustained periods, they may close the effectiveness gap between home-care products and professionally administered in-pocket gels.

Putting HA into a complete oral care routine

Hyaluronic acid is not a substitute for foundational oral hygiene. Brushing twice daily, cleaning between teeth daily, and attending regular professional scaling appointments remain the pillars of oral health for the vast majority of people. HA is best understood as a targeted, evidence-informed adjunct for individuals already experiencing gum inflammation, recovering from dental procedures, or managing recurrent oral ulcers.

For someone managing mild generalised gingivitis at home, an HA-containing mouthwash used in the evening after brushing and flossing is a reasonable addition. The mechanism is plausible, the risk profile is low, and the evidence base, while limited, is consistently positive in direction. For established periodontitis, in-pocket HA gels delivered professionally after scaling offer the strongest evidence and the best concentration-to-tissue contact ratio of any currently available format.

Enamel remineralisation is a parallel but distinct priority. While HA supports soft tissue architecture, enamel repair requires a different toolset: fluoride or nano-hydroxyapatite to replenish mineral, xylitol to reduce the proportion of acid-producing Streptococcus mutans in the plaque biofilm, and dietary habits that limit acid exposure to below the critical demineralisation threshold of pH 5.5. Enamel is approximately 97% hydroxyapatite by weight, and once lost it cannot regenerate from gingival tissue health alone.

Minvelle remineralising gum focuses on this enamel side of the equation. Its nine ingredients, including nano-hydroxyapatite (approved in Japan since 1993 as an anti-cavity agent and by the European SCCS in 2023), xylitol, Chios mastic resin, erythritol, calcium bentonite clay, eggshell calcium, myrrh, acacia gum, and natural spearmint oil, work to protect and rebuild enamel with each chewing session. It does not contain hyaluronic acid, which is more commonly formulated into dedicated periodontal gel or serum products. If gum tissue health is a concern alongside enamel protection, combining a remineralising gum with a clinically tested HA product addresses both targets through complementary mechanisms.

Diet also plays a systemic role in gum tissue quality. Ultra-processed foods, refined sugars, and diets high in seed oils drive background systemic inflammation that is reflected in gingival health. Dietary patterns associated with lower inflammatory markers, such as higher omega-3 intake, greater polyphenol consumption, and adequate vitamins C and D, correlate with better periodontal outcomes in observational studies. HA supplementation in the mouth addresses the local tissue environment, but systemic inflammation is the soil in which periodontal disease grows, and dietary choices shape that soil.

Frequently asked questions